School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University, Taichung 404, Taiwan.
J Agric Food Chem. 2011 Sep 14;59(17):9112-9. doi: 10.1021/jf201375u. Epub 2011 Aug 5.
This study investigated the analgesic effects of taraxeren-3-one, which is an ingredient from Diospyros maritima (DM), using the models of acetic acid-induced writhing response and the formalin test, and its anti-inflammatory effects using the model of λ-carrageenan (Carr)-induced paw edema. Treatment of male ICR mice with taraxeren-3-one inhibited the numbers of writhing response and formalin-induced pain in the late phase, significantly. In the anti-inflammatory test, taraxeren-3-one decreased paw edema at 4 and 5 h after Carr administration and increased the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione (GSH) in the liver tissue at 5 h after Carr injection. Taraxeren-3-one affects malondialdehyde (MDA), nitric oxide (NO), and tumor necrosis factor-α (TNF-α) levels from both the edema paw and serum at 5 h after Carr injection. Western blotting revealed that taraxeren-3-one decreased Carr-induced inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) expressions. These anti-inflammatory mechanisms of taraxeren-3-one might be related to the decrease in the level of MDA in the edema paw via increasing the activities of SOD, CAT, GPx, and GSH in the liver. Also, taraxeren-3-one could affect the production of NO and TNF-α and, therefore, affect the anti-inflammatory effects.
本研究采用醋酸扭体法和福尔马林试验模型考察了来自 Diospyros maritima(DM)的有效成分 taraxeren-3-one 的镇痛作用,并采用 λ-角叉菜胶(Carr)诱导的爪肿胀模型考察其抗炎作用。雄性 ICR 小鼠给予 taraxeren-3-one 治疗可显著抑制扭体反应次数和福尔马林诱导的疼痛反应后期的疼痛。在抗炎试验中,taraxeren-3-one 可降低 Carr 给药后 4 和 5 小时的爪肿胀,并增加 Carr 注射后 5 小时肝组织中超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GPx)和谷胱甘肽(GSH)的活性。Taraxeren-3-one 可影响 Carr 注射后 5 小时肿胀足和血清中的丙二醛(MDA)、一氧化氮(NO)和肿瘤坏死因子-α(TNF-α)水平。Western blot 分析显示,taraxeren-3-one 可降低 Carr 诱导的诱导型一氧化氮合酶(iNOS)和环氧化酶-2(COX-2)的表达。Taraxeren-3-one 的这些抗炎机制可能与通过增加肝组织中 SOD、CAT、GPx 和 GSH 的活性降低肿胀足 MDA 水平有关。此外,taraxeren-3-one 可能影响 NO 和 TNF-α 的产生,从而影响抗炎作用。